Entering text into the input field will update the search result below

REGENXBIO, Inc. (RGNX) CEO Kenneth Mills on Q1 2020 Results - Earnings Call Transcript

May 07, 2020 10:56 PM ETREGENXBIO Inc. (RGNX)
SA Transcripts profile picture
SA Transcripts

REGENXBIO, Inc. (NASDAQ:RGNX) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET

Company Participants

Patrick Christmas - Senior Vice President and General Counsel

Kenneth Mills - President and Chief Executive Officer

Stephen Pakola - Chief Medical Officer

Vittal Vasista - Chief Financial Officer

Conference Call Participants

Gena Wang - Barclays

Gbola Amusa - Chardan Capital Markets

Mani Foroohar - SVB Leerink

Costas Liappas - Morgan Stanley


Good afternoon, and welcome to the REGENXBIO First Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will be given at that time. As a reminder, this conference call is being recorded.

I would now like to turn the call over to Mr. Patrick Christmas, Senior Vice President and General Counsel for REGENXBIO. You may begin.

Patrick Christmas

Good afternoon and thank you for joining us today. With us are Ken Mills, REGENXBIO's President and Chief Executive Officer; Dr. Steve Pakola, our Chief Medical Officer; and Vit Vasista, our Chief Financial Officer.

Earlier this afternoon, REGENXBIO released financial and operating results for the first quarter ended March 31, 2020. The press release reporting our financial results is available on our website at www.regenxbio.com.

Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted and can be identified by words such as expect, plan, will, may, anticipate, believe, should, intend, and other words of similar meaning.

Any such forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties. These risks are described in the Risk Factors in the Management's Discussion and Analysis sections of REGENXBIO's Annual

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About RGNX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on RGNX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.